BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33998265)

  • 1. Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez.
    Hotez P
    Future Microbiol; 2021 May; 16():539-541. PubMed ID: 33998265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Wolynn T; Hermann C
    Nat Immunol; 2021 Sep; 22(9):1068-1070. PubMed ID: 34429551
    [No Abstract]   [Full Text] [Related]  

  • 3. The Science and Art of Vaccinology During the COVID-19 Pandemic.
    Romero JR; Bernstein HH
    Pediatr Ann; 2020 Dec; 49(12):e506-e508. PubMed ID: 33290567
    [No Abstract]   [Full Text] [Related]  

  • 4. Trajectory of COVID-19 Vaccine Hesitancy Over Time and Association of Initial Vaccine Hesitancy With Subsequent Vaccination.
    Siegler AJ; Luisi N; Hall EW; Bradley H; Sanchez T; Lopman BA; Sullivan PS
    JAMA Netw Open; 2021 Sep; 4(9):e2126882. PubMed ID: 34559232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Should Psychiatry Respond to COVID-19 Anti-Vax Attitudes?
    Goldberg JF
    J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34428357
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunology of SARS-CoV-2 infections and vaccines.
    Grigoryan L; Pulendran B
    Semin Immunol; 2020 Aug; 50():101422. PubMed ID: 33262067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring confidence in vaccines in the COVID-19 era.
    Verger P; Dubé E
    Expert Rev Vaccines; 2020 Nov; 19(11):991-993. PubMed ID: 32940574
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines for SARS coronavirus 2 and the new normal in vaccinology.
    Griffiths PD
    Rev Med Virol; 2021 Mar; 31(2):e2229. PubMed ID: 33666285
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccines for neglected, emerging and re-emerging diseases.
    Madhav A; Mehrotra T; Sinha P; Mutreja A
    Semin Immunol; 2020 Aug; 50():101423. PubMed ID: 33250352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Shot Wonder: A Vaccine Against All Coronaviruses.
    Mertz L
    IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.
    Di Gennaro F; Murri R; Segala FV; Cerruti L; Abdulle A; Saracino A; Bavaro DF; Fantoni M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33652829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccination and the Challenge of Infodemic and Disinformation.
    Farooq F; Rathore FA
    J Korean Med Sci; 2021 Mar; 36(10):e78. PubMed ID: 33724740
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Challenges in Vaccinology.
    Lavelle EC; Carsetti R; Pickl WF; Wiedermann U
    Front Immunol; 2020; 11():632537. PubMed ID: 33391292
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors.
    Razai MS; Oakeshott P; Esmail A; Wiysonge CS; Viswanath K; Mills MC
    J R Soc Med; 2021 Jun; 114(6):295-298. PubMed ID: 34077688
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and the rise of anti-science.
    Hotez P
    Expert Rev Vaccines; 2021 Mar; 20(3):227-229. PubMed ID: 33599568
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19 vaccine hesitancy among ethnic minority groups.
    Razai MS; Osama T; McKechnie DGJ; Majeed A
    BMJ; 2021 Feb; 372():n513. PubMed ID: 33637577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming vaccine development.
    Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
    Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.